Assay provider results from the probe development effort to identify inhibitors of prolyl oligopeptidase-like enzyme (PREPL): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of PREPL in a complex proteome
Name: Assay provider results from the probe development effort to identify inhibitors of prolyl oligopeptidase-like enzyme (PREPL): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of PREPL in a complex proteome. ..more
BioActive Compounds: 11
Depositor Specified Assays
Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC)
Affiliation: The Scripps Research Institute, TSRI
Assay Provider: Alan Saghatelian, Harvard University
Network: Molecular Library Probe Production Centers Network (MLPCN)
Grant Proposal Number: 1 DP2 OD002374-01 Fast Track
Grant Proposal PI: Alan Saghatelian, Harvard University
External Assay ID: PREPL_INH_FLINT_1X%INH_PROTEOME
Name: Assay provider results from the probe development effort to identify inhibitors of prolyl oligopeptidase-like enzyme (PREPL): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of PREPL in a complex proteome.
Hypotonia-cystinuria syndrome (HCS) and 2p21 deletion syndrome are debilitating and poorly understood diseases, both involving deletion of the gene encoding prolyl oligopeptidase-like enzyme (PREPL), a member of the prolyl oligopeptidase (POP) family of serine peptidases (1). Saghatelian and colleagues have developed an advanced LC-MS-based peptide metabolite profiling platform that allows linkage of enzymes with their endogenous substrates and establishment of their participation in specific biochemical networks; however, doing so requires selective chemical tools to functionally perturb the enzymes of interest (2). They used this technology to annotate the uncharacterized enzyme KIAA1363 (3) and to identify a series of peptide substrates in the kidney for another POP family member, DPP4 (4). Importantly, substrate identification for KIAA1363 was only accomplished through the application of a selective small molecule KIAA1363 inhibitor, as constitutive inhibition produced widespread metabolic disturbances (3). Initial attempts at identifying the substrate specificity of PREPL have not been successful. Physicochemical properties of PREPL suggest that endogenous protein-protein interactions with PREPL might lead to an active form of PREPL that cannot be recapitulated in vitro. Therefore, the ability to target PREPL in vivo is a necessary step in understanding the function of this important peptidase enzyme. Development of selective inhibitors of PREPL would provide crucial tools to advance understanding of the physiological and pathological roles of this critical enzyme and might reveal new treatment possibilities for HCS and 2p21 deletion syndrome (5).
1. Martens, K., et al., Global distribution of the most prevalent deletions causing hypotonia-cystinuria syndrome. Eur J Hum Genet, 2007. 15(10): p. 1029-33.
2. Saghatelian, A., et al., Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry, 2004. 43(45): p. 14332-9.
3. Chiang, K.P., et al., An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem Biol, 2006. 13(10): p. 1041-50.
4. Tagore, D.M., et al., Peptidase substrates via global peptide profiling. Nat Chem Biol, 2009. 5(1): p. 23-5. Jaeken, J., et al., Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. Am J Hum Genet, 2006. 78(1): p. 38-51.
5. Jaeken, J., et al., Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. Am J Hum Genet, 2006. 78(1): p. 38-51.
Assay provider, Prolyl oligopeptidase-like enzyme, PREPL, FLJ16627, KIAA0436, serine protease, hypotonia-cystinuria syndrome, HCS, 2p21 deletion syndrome, inhibit, inhibitor, inhibition, activity-based protein profiling, ABPP, fluorescence, gel-based, fluorophosphonate rhodamine, FP-Rh, Scripps, The Scripps Research Institute Molecular Screening Center, SRIMSC, Molecular Libraries Probe Production Centers Network, MLPCN.
The purpose of this assay is to determine whether test compounds can inhibit Prepl in the context of a complex proteome using an activity-based proteomic profiling (ABPP) assay. In this assay, a complex proteome containing Prepl is incubated with test compound followed by reaction with a rhodamine-conjugated fluorophosphonate (FP-Rh) activity-based probe. The reaction products are separated by SDS-PAGE and visualized in-gel using a flatbed fluorescence scanner. The percentage activity remaining is determined by measuring the integrated optical density (IOD) of the bands. As designed, test compounds that act as inhibitors will prevent enzyme-probe interactions, thereby decreasing the proportion of bound fluorescent probe, giving lower fluorescence intensity in the band in the gel. Percent inhibition is calculated relative to a DMSO (no compound) control.
Mouse brain proteome (1 mg/mL in PBS, pH 7.4) was spiked with purified recombinant mouse Prepl (40 nM final concentration) and pluronic detergent was added to a final concentration of 0.01%. Samples were incubated with DMSO or inhibitor (50 uM inhibitor final concentration) for 30 minutes at room temperature. FP-Rh was then added at a final concentration of 0.5 uM. After 15 minutes at room temperature, the reactions were quenched with SDS-PAGE loading buffer, resolved by SDS-PAGE and visualized by in-gel fluorescent scanning. The percentage activity remaining was determined by measuring the integrated optical density of the target band relative to a DMSO-only (no compound) control.
The % inhibition was then calculated as follows:
%_Inhibition = ( 1 - ( IOD_Test_Compound - Median_IOD_Low_Control ) / ( Median_IOD_High_Control - Median_IOD_Low_Control ) ) * 100
Test_Compound is defined as target treated with test compound.
High_Control is defined as target treated with DMSO only (no compound).
Low_Control is defined as background in a blank region of the gel.
PubChem Activity Outcome and Score:
Compounds with greater than 20% inhibition were considered active. Compounds with less than or equal to 20% inhibition were considered inactive.
The reported PubChem Activity Score has been normalized to 100% observed inhibition. Negative % inhibition values are reported as activity score zero.
The PubChem Activity Score range for active compounds is 100-35, and for inactive compounds 24-0.
List of Reagents:
Mouse brain proteome (provided by Assay Provider)
Recombinant Prepl (Open Biosystems clone ID 3585402)
FP-Rh (Pierce 88318)
PBS (Cellgro 20-031-CV)
Pluronic detergent (Invitrogen, P-6866)
This assay was performed by the assay provider with liquid samples of test compounds.
** Test Concentration.
Data Table (Concise)